SECURITIES AND EXCHANGE COMMISSION
                                   Washington, D.C.

          Litigation Release No. 15692 / April 2, 1998

          Securities  and Exchange Commission v. Eva-Health, USA, Inc., and
          Calman H. Rifkin No. 97. Civ. 9288 (LBS) (S.D.N.Y.)

               The Securities  and Exchange Commission ("Commission") today
          announced that on March  30,  1998,  the  United  States District
          Court for the Southern District of New York entered a judgment by
          default against defendant Eva-Health, USA, Inc. ("Eva-Health"), a
          company  that  purportedly  was  in  the business of researching,
          developing, manufacturing, and licensing biomedical devices.

               In a complaint filed on December  17,  1997,  the Commission
          alleged  that,  from January 1992 through April 1994,  Eva-Health
          sold  approximately   $5.5  million  of  unregistered  Eva-Health
          warrants ("Warrants") to  investors.  The Commission alleged that
          Eva-Health  and its former Chief  Executive  Officer,  Calman  H.
          Rifkin ("Rifkin"),  violated Sections 5(a), 5(c) and 17(a) of the
          Securities Act of 1933  ("Securities  Act")  and Section 10(b) of
          the  Securities Exchange Act of 1934 ("Exchange  Act")  and  Rule
          10b-5 thereunder, when they made fraudulent misrepresentations to
          investors   concerning,  inter  alia,  Rifkin's  educational  and
          professional credentials and the existence of patents purportedly
          held by Eva-Health for eleven biomedical devices.

               The Honorable  Leonard B. Sand of the United States District
          Court for the Southern  District  of New York issued the judgment
          by  default  against  Eva-Health  enjoining   it   from   further
          violations of Sections 5(a), 5(c) and 17(a) of the Securities Act
          and  Section 10(b) of the Exchange Act and Rule 10b-5 thereunder,
          after  Eva-Health  failed  to  answer the Commission's complaint.
          Eva-Health  was also ordered to disgorge  $4,493,850  in  illegal
          profits, plus $1,871,192 in prejudgment interest.

               For further  information  See  Litigation Release No. 15594,
          December 16, 1997.